Tvardi Therapeutics (TVRD) Total Assets by Year
Tvardi Therapeutics, Inc. closed fiscal year 2025 with $32.1M in total assets, $11.1M in total liabilities and $20.9M in shareholder equity. Total assets fell 8.9% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Tvardi Therapeutics, Inc. has filed alongside them.
Ticker history: CARA became TVRD (Tvardi Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View CARA history.
Annual figures, oldest first. Point at a bar to read its period.
TVRD Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $32.1M-8.9% | $35.2M-72.0% | $125.8M-30.9% | $182.2M-26.2% | $247.1M-8.9% | $271.2M+16.4% | $233.0M+22.1% | $190.8M+96.7% | $97.0M+52.0% | $63.8M-42.4% | $110.9M+98.3% | $55.9M+209.3% | $18.1M | N/A |
| Total Liabilities | $11.1M-91.2% | $126.3M-32.8% | $187.9M+701.0% | $23.5M+20.1% | $19.5M-11.8% | $22.2M-52.1% | $46.2M-19.1% | $57.2M+459.4% | $10.2M-22.0% | $13.1M+123.9% | $5.9M+37.0% | $4.3M-94.1% | $72.2M | N/A |
| Total Equity | $20.9Mn/m | -$91.1Mn/m | -$62.1M-139.1% | $158.8M-30.2% | $227.5M-8.6% | $249.0M+33.4% | $186.7M+39.7% | $133.6M+54.0% | $86.8M+71.1% | $50.7M-51.7% | $105.0M+103.3% | $51.7Mn/m | -$54.1Mn/m | -$58.1M |
TVRD Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.5M-60.0% | $25.8M-33.7% | $32.1M-8.9% | $39.0M-24.0% | $43.8M-39.7% | $38.9M-56.8% | $35.2M-72.0% | $51.3M-55.5% | $72.5M-46.1% | $90.1M-41.2% | $125.8M-30.9% | $115.3M-46.0% |
| Total Liabilities | $9.1M-15.6% | $11.3M-91.9% | $11.1M-91.2% | $11.2M-91.4% | $10.8M-92.6% | $139.6M-10.7% | $126.3M-32.8% | $129.8M+337.2% | $145.6M+471.8% | $156.3M+837.0% | $187.9M+701.0% | $29.7M+3.5% |
| Total Equity | $8.4M-74.5% | $14.5Mn/m | $20.9Mn/m | $27.9Mn/m | $32.9Mn/m | -$100.6Mn/m | -$91.1Mn/m | -$78.5M-191.7% | -$73.1M-167.1% | -$66.2M-148.4% | -$62.1M-139.1% | $85.6M-53.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Tvardi Therapeutics, Inc. financials
Frequently Asked Questions
Tvardi Therapeutics, Inc. closed fiscal year 2025 with $32.1M in total assets, $11.1M in total liabilities and $20.9M in shareholder equity.
Tvardi Therapeutics, Inc. (TVRD) total assets fell by 8.9% year over year, from $35.2M to $32.1M in fiscal year 2025.
Tvardi Therapeutics, Inc. (TVRD) reported $17.5M in total assets in Q2 2026. This represents a decrease of 60.0% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Tvardi Therapeutics, Inc. (TVRD) reported on that line in every period on record.